Health Trials

Rendu Osler Disease

1

Review clinical trials related to Rendu Osler Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

The goal of this clinical trial is to evaluate in real life, in patients with Hereditary Hemorrhagic Telangiectasia (HHT), the tolerance of the strategy of use of anticoagulant and/or antiplatelet, by comparing a new exposure period (first trimester of treatment) to a period of reference non-exposure (last trimester before start of treatment).

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, Clermont-FerrandUpdated: Apr 9, 2025Locations: 18
Eligibility criteria

Patient with Rendu-Osler disease with an indication of antiplatelet and/or antic... [+3]

Patient with an indication of antiplatelet and/or anticoagulant but for whom tre... [+3]

Read more